Bimekizumab provided rapid improvements in patient-reported symptoms and health-related quality of life in patients with active psoriatic arthritis: pooled 16-week results from two phase 3 studies
Husni, M Elaine, Mease, Philip J, Merola, Joseph F, Tillett, William, Goldammer, Nadine, Ink, Barbara, Coarse, Jason, Lambert, Jérémy, Taieb, Vanessa, Gladman, Dafna D
Published in Rheumatic & musculoskeletal diseases open (23.09.2024)
Published in Rheumatic & musculoskeletal diseases open (23.09.2024)
Get full text
Journal Article
Modification of Nuclear PML Protein by SUMO-1 Regulates Fas-Induced Apoptosis in Rheumatoid Arthritis Synovial Fibroblasts
Meinecke, Ingmar, Cinski, Antje, Baier, Anja, Peters, Marvin A., Dankbar, Berno, Wille, Aline, Drynda, Andreas, Mendoza, Heidi, Gay, Renate E., Hay, Ronald T., Ink, Barbara, Gay, Steffen, Pap, Thomas
Published in Proceedings of the National Academy of Sciences - PNAS (20.03.2007)
Published in Proceedings of the National Academy of Sciences - PNAS (20.03.2007)
Get full text
Journal Article
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis
Gossec, Laure, Orbai, Ana-Maria, Coates, Laura C, Gladman, Dafna D, Ogdie, Alexis, Pelligra, Christopher G, Ciaravino, Valérie, Ink, Barbara, Taieb, Vanessa, Lambert, Jérémy, de Wit, Maarten
Published in Rheumatic & musculoskeletal diseases open (31.01.2024)
Published in Rheumatic & musculoskeletal diseases open (31.01.2024)
Get full text
Journal Article
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL
Coates, Laura C, Landewé, Robert, McInnes, Iain B, Mease, Philip J, Ritchlin, Christopher T, Tanaka, Yoshiya, Asahina, Akihiko, Behrens, Frank, Gladman, Dafna D, Gossec, Laure, Orbai, Ana-Maria, Gottlieb, Alice B, Warren, Richard B, Ink, Barbara, Bajracharya, Rajan, Shende, Vishvesh, Coarse, Jason, Merola, Joseph F
Published in Rheumatic & musculoskeletal diseases open (22.02.2024)
Published in Rheumatic & musculoskeletal diseases open (22.02.2024)
Get full text
Journal Article
Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
Mease, Philip J., Merola, Joseph F., Tanaka, Yoshiya, Gossec, Laure, McInnes, Iain B., Ritchlin, Christopher T., Landewé, Robert B. M., Asahina, Akihiko, Ink, Barbara, Heinrichs, Andrea, Bajracharya, Rajan, Shende, Vishvesh, Coarse, Jason, Coates, Laura C.
Published in Rheumatology and therapy. (01.10.2024)
Published in Rheumatology and therapy. (01.10.2024)
Get full text
Journal Article
NEDP1, a Highly Conserved Cysteine Protease That deNEDDylates Cullins
Mendoza, Heidi M., Shen, Lin-nan, Botting, Catherine, Lewis, Alan, Chen, Jingwen, Ink, Barbara, Hay, Ronald T.
Published in The Journal of biological chemistry (11.07.2003)
Published in The Journal of biological chemistry (11.07.2003)
Get full text
Journal Article
51569 Bimekizumab treatment resulted in sustained improvements in nail psoriasis and signs and symptoms of psoriatic arthritis in patients with baseline nail disease: 1-year pooled results from two phase 3 studies
Merola, Joseph F., Thaçi, Diamant, Ink, Barbara, Bajracharya, Rajan, Lambert, Jérémy, Coarse, Jason, Gottlieb, Alice B.
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)
McInnes, Iain B, Asahina, Akihiko, Coates, Laura C, Landewé, Robert, Merola, Joseph F, Ritchlin, Christopher T, Tanaka, Yoshiya, Gossec, Laure, Gottlieb, Alice B, Warren, Richard B, Ink, Barbara, Assudani, Deepak, Bajracharya, Rajan, Shende, Vishvesh, Coarse, Jason, Mease, Philip J
Published in The Lancet (British edition) (07.01.2023)
Published in The Lancet (British edition) (07.01.2023)
Get full text
Journal Article
51609 Bimekizumab treatment resulted in sustained improvements in pain and fatigue in patients with active psoriatic arthritis and baseline psoriasis: 1-year results from two phase 3 studies
Gottlieb, Alice B., Merola, Joseph F., Ink, Barbara, Bajracharya, Rajan, Lambert, Jérémy, Coarse, Jason, Warren, Richard B.
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
51558 Bimekizumab treatment resulted in rapid and sustained improvement in total and individual Bath Ankylosing Spondylitis Disease Activity Index components in patients with psoriatic arthritis: 1-year results from two phase 3 studies
Merola, Joseph F., Gottlieb, Alice B., Ink, Barbara, Bajracharya, Rajan, Lambert, Jérémy, Coarse, Jason, Favalli, Ennio G.
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial
Ritchlin, Christopher T, Kavanaugh, Arthur, Merola, Joseph F, Schett, Georg, Scher, Jose U, Warren, Richard B, Gottlieb, Alice B, Assudani, Deepak, Bedford-Rice, Kathy, Coarse, Jason, Ink, Barbara, McInnes, Iain B
Published in The Lancet (British edition) (08.02.2020)
Published in The Lancet (British edition) (08.02.2020)
Get full text
Journal Article
P189 Bimekizumab in patients with psoriatic arthritis with prior inadequate response to TNF inhibitors: improvements of PsARC over 16 weeks in the Phase 3 BE COMPLETE trial
Sharma, Poonam, Jadon, Deepak R, McGonagle, Dennis, Ink, Barbara, Assudani, Deepak, Taieb, Vanessa, Coates, Laura C
Published in Rheumatology (Oxford, England) (24.04.2023)
Published in Rheumatology (Oxford, England) (24.04.2023)
Get full text
Journal Article
P171 Bimekizumab in bDMARD-naïve patients with active psoriatic arthritis: improvements in PsARC over 24 weeks in the Phase 3 BE OPTIMAL trial
McInnes, Iain, Ink, Barbara, Bajracharya, Rajan, Taieb, Vanessa, Tillett, William R
Published in Rheumatology (Oxford, England) (24.04.2023)
Published in Rheumatology (Oxford, England) (24.04.2023)
Get full text
Journal Article
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)
Merola, Joseph F, Landewé, Robert, McInnes, Iain B, Mease, Philip J, Ritchlin, Christopher T, Tanaka, Yoshiya, Asahina, Akihiko, Behrens, Frank, Gladman, Dafna D, Gossec, Laure, Gottlieb, Alice B, Thaçi, Diamant, Warren, Richard B, Ink, Barbara, Assudani, Deepak, Bajracharya, Rajan, Shende, Vishvesh, Coarse, Jason, Coates, Laura C
Published in The Lancet (British edition) (07.01.2023)
Published in The Lancet (British edition) (07.01.2023)
Get full text
Journal Article
P171 Bimekizumab impact on core group for research and assessment of psoriasis and psoriatic arthritis domains for patients with psoriatic arthritis: 52-week results from four phase 3 studies
Merola, Joseph F, Mease, Philip J, Deodhar, Atul, Ink, Barbara, Fleurinck, Carmen, Bajracharya, Rajan, Coarse, Jason, Coates, Laura C
Published in Rheumatology (Oxford, England) (24.04.2024)
Published in Rheumatology (Oxford, England) (24.04.2024)
Get full text
Journal Article
E070 Sustained and consistent efficacy of bimekizumab in patients with active psoriatic arthritis regardless of prior TNF-inhibitor status: results from the phase 3 BE OPTIMAL and BE COMPLETE trials
Tillett, William R, Ink, Barbara, Bajracharya, Rajan, Taieb, Vanessa, Sharma, Poonam, McGonagle, Dennis, Coates, Laura C, McInnes, Iain B
Published in Rheumatology (Oxford, England) (24.04.2024)
Published in Rheumatology (Oxford, England) (24.04.2024)
Get full text
Journal Article
E069 Bimekizumab maintained efficacy responses through 52 weeks in patients with psoriatic arthritis and inadequate response or intolerance to tumour necrosis factor inhibitors who were responders at week 16: results from a phase 3, randomised study
Tillett, William R, Merola, Joseph F, Tanaka, Yoshiya, Favalli, Ennio G, McGonagle, Dennis, Thaçi, Diamant, Walsh, Jessica A, Ink, Barbara, Bajracharya, Rajan, Coarse, Jason, Ritchlin, Christopher T
Published in Rheumatology (Oxford, England) (24.04.2024)
Published in Rheumatology (Oxford, England) (24.04.2024)
Get full text
Journal Article
E067 Bimekizumab maintained efficacy responses through 52 weeks in biologic disease-modifying antirheumatic drugnaïve patients with psoriatic arthritis who were responders at week 16: results from BE OPTIMAL, a phase 3, activereference study
Tillett, William R, Merola, Joseph F, Tanaka, Yoshiya, Favalli, Ennio G, McGonagle, Dennis, Walsh, Jessica A, Thaçi, Diamant, Ink, Barbara, Bajracharya, Rajan, Taieb, Vanessa, Ritchlin, Christopher T
Published in Rheumatology (Oxford, England) (24.04.2024)
Published in Rheumatology (Oxford, England) (24.04.2024)
Get full text
Journal Article
43744 Bimekizumab in bDMARD-naïve patients with psoriatic arthritis and skin involvement: Analysis of radiographic progression at Week 16 of BE OPTIMAL, a phase 3, multicenter, randomized, placebo- controlled, active reference study
Merola, Joseph F., Asahina, Akihiko, Gisondi, Paolo, Thaçi, Diamant, Gladman, Dafna D., Ink, Barbara, Assudani, Deepak, Bajracharya, Rajan, Coarse, Jason, Landewé, Robert
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
43024 Bimekizumab improves joint measures in patients with active psoriatic arthritis and moderate or severe psoriasis: Pooled 16-week results from phase 3 randomized, placebo-controlled studies BE OPTIMAL and BE COMPLETE
Gottlieb, Alice B., Asahina, Akihiko, Merola, Joseph F., McInnes, B., Boehncke, Wolf- Henning, Lebwohl, Mark, Thaçi, Diamant, Ink, Barbara, Bajracharya, Rajan, Coarse, Jason, Warren, Richard B.
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article